Intravenous Exenatide in Patients With Acute Brain Injury

NCT02058940 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Brain Injuries

Interventions

DRUG: Exenatide

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]
[object Object]